Lymph node-positive bladder cancer: Surgical, pathologic, molecular and prognostic aspects

Jose A. Pedrosa, Michael Koch, Liang Cheng

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discussed in the current literature and a more extensive pelvic lymph node dissection and thorough pathologic assessment has been advocated. It is clear that stratification using the tumor node metastasis staging system is insufficient to adequately discriminate prognosis between patients with different lymph node involvement. Lymph node density and extranodal extension have been extensively investigated and appear to influence the prognosis of these patients. Molecular markers have been developed to improve the diagnosis of micrometastatic disease, and new targeted therapies have shown promising preclinical results and are now being tested in different clinical scenarios.

Original languageEnglish
Pages (from-to)1281-1295
Number of pages15
JournalExpert Review of Anticancer Therapy
Volume13
Issue number11
DOIs
StatePublished - 2013

Fingerprint

Urinary Bladder Neoplasms
Lymph Nodes
Lymphatic Metastasis
Lymph Node Excision
Neoplasm Metastasis
Drug Therapy
Survival
Neoplasms
Therapeutics

Keywords

  • lymph node density
  • lymph node dissection/pelvic lymphadenectomy
  • lymph node-positive bladder cancer
  • staging
  • targeted therapy
  • transitional cell (urothelial) carcinoma
  • urinary bladder

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Lymph node-positive bladder cancer : Surgical, pathologic, molecular and prognostic aspects. / Pedrosa, Jose A.; Koch, Michael; Cheng, Liang.

In: Expert Review of Anticancer Therapy, Vol. 13, No. 11, 2013, p. 1281-1295.

Research output: Contribution to journalArticle

@article{fcf23a7d2b5c4b15a2296b172b5410db,
title = "Lymph node-positive bladder cancer: Surgical, pathologic, molecular and prognostic aspects",
abstract = "The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discussed in the current literature and a more extensive pelvic lymph node dissection and thorough pathologic assessment has been advocated. It is clear that stratification using the tumor node metastasis staging system is insufficient to adequately discriminate prognosis between patients with different lymph node involvement. Lymph node density and extranodal extension have been extensively investigated and appear to influence the prognosis of these patients. Molecular markers have been developed to improve the diagnosis of micrometastatic disease, and new targeted therapies have shown promising preclinical results and are now being tested in different clinical scenarios.",
keywords = "lymph node density, lymph node dissection/pelvic lymphadenectomy, lymph node-positive bladder cancer, staging, targeted therapy, transitional cell (urothelial) carcinoma, urinary bladder",
author = "Pedrosa, {Jose A.} and Michael Koch and Liang Cheng",
year = "2013",
doi = "10.1586/14737140.2013.850847",
language = "English",
volume = "13",
pages = "1281--1295",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Lymph node-positive bladder cancer

T2 - Surgical, pathologic, molecular and prognostic aspects

AU - Pedrosa, Jose A.

AU - Koch, Michael

AU - Cheng, Liang

PY - 2013

Y1 - 2013

N2 - The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discussed in the current literature and a more extensive pelvic lymph node dissection and thorough pathologic assessment has been advocated. It is clear that stratification using the tumor node metastasis staging system is insufficient to adequately discriminate prognosis between patients with different lymph node involvement. Lymph node density and extranodal extension have been extensively investigated and appear to influence the prognosis of these patients. Molecular markers have been developed to improve the diagnosis of micrometastatic disease, and new targeted therapies have shown promising preclinical results and are now being tested in different clinical scenarios.

AB - The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discussed in the current literature and a more extensive pelvic lymph node dissection and thorough pathologic assessment has been advocated. It is clear that stratification using the tumor node metastasis staging system is insufficient to adequately discriminate prognosis between patients with different lymph node involvement. Lymph node density and extranodal extension have been extensively investigated and appear to influence the prognosis of these patients. Molecular markers have been developed to improve the diagnosis of micrometastatic disease, and new targeted therapies have shown promising preclinical results and are now being tested in different clinical scenarios.

KW - lymph node density

KW - lymph node dissection/pelvic lymphadenectomy

KW - lymph node-positive bladder cancer

KW - staging

KW - targeted therapy

KW - transitional cell (urothelial) carcinoma

KW - urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=84887294618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887294618&partnerID=8YFLogxK

U2 - 10.1586/14737140.2013.850847

DO - 10.1586/14737140.2013.850847

M3 - Article

C2 - 24134387

AN - SCOPUS:84887294618

VL - 13

SP - 1281

EP - 1295

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 11

ER -